PK
Purshottam Kant Bajpai
About Purshottam Kant Bajpai
Data last updated:
Purshottam Kant Bajpai is a Director at Value Formulations Private Limited (since 2015), Director at Ultravalue Pharmaceuticals Private Limited (since 2022) and Director at Valuemoney Nidhi Limited (since 2021). The companies operate in Pharma and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹19.63 Cr; the largest is Value Formulations Private Limited at ₹9.88 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Aug 2015 | 2011 | ₹9.88 Cr (FY 2024) | Active | |
| Director | 10 Jun 2022 | 2022 | ₹9.75 Cr (FY 2024) | Active | |
| Director | 06 Feb 2021 | 2021 | Active |
Board colleagues of Purshottam Kant Bajpai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vineeta Bajpai | 03422334 | Value Formulations Private Limited , Valuemoney Nidhi Limited | Director |
| Amit Kumar Anit | 09633577 | Ultravalue Pharmaceuticals Private Limited | Director |
| Lalan Singh | 09633576 | Ultravalue Pharmaceuticals Private Limited | Director |
| Mahesh Prasad Singh | 05118394 | Ultravalue Pharmaceuticals Private Limited | Director |
| Rakesh Kumar | 05157232 | Ultravalue Pharmaceuticals Private Limited | Director |
| Neeraj Kumar Misra | 09056712 | Valuemoney Nidhi Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Purshottam Kant Bajpai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Purshottam Kant Bajpai
Purshottam Kant Bajpai currently holds 3 directorships: Value Formulations Private Limited (Director, since 12 Aug 2015, revenue ₹9.88 Cr (FY 2024)); Ultravalue Pharmaceuticals Private Limited (Director, since 10 Jun 2022, revenue ₹9.75 Cr (FY 2024)); Valuemoney Nidhi Limited (Director, since 06 Feb 2021).
Purshottam Kant Bajpai was first appointed on 12 Aug 2015 as Director at Value Formulations Private Limited. The most recent appointment on record is 10 Jun 2022 at Ultravalue Pharmaceuticals Private Limited.
The 2 current companies of Purshottam Kant Bajpai that report revenue have a combined latest revenue of ₹19.63 Cr: Value Formulations Private Limited ₹9.88 Cr (FY 2024); Ultravalue Pharmaceuticals Private Limited ₹9.75 Cr (FY 2024).
The current boards of Purshottam Kant Bajpai's companies include Vineeta Bajpai (Value Formulations Private Limited), Amit Kumar Anit (Ultravalue Pharmaceuticals Private Limited), Lalan Singh (Ultravalue Pharmaceuticals Private Limited), Mahesh Prasad Singh (Ultravalue Pharmaceuticals Private Limited), Rakesh Kumar (Ultravalue Pharmaceuticals Private Limited), Neeraj Kumar Misra (Valuemoney Nidhi Limited).